Molecular Templates saw no growth in patent filings and highest growth of 1.66% in grants in April in Q2 2024. Compared to Q1 2024, Q2 2024 saw no growth in patent filings and grants by 1.66%. GlobalData’s DataBook provides a comprehensive analysis of Molecular Templates‘s patent filings and grants. Buy the databook here.
Molecular Templates has been focused on protecting inventions in Israel(IL) with five publications in Q2 2024
The Israel(IL) Patent Office dominates the patent grants with nearly 50% of grants. The United States(US), Israel(IL), China(CN), and Spain(ES) patent Office are among the top ten patent offices where Molecular Templates is filings its patents. Among the top granted patent authorities, Molecular Templates has 50% of its grants in Israel(IL), 30% in China(CN) and 10% in Spain(ES).
Roche and Johnson & Johnson could be the strongest competitors for Molecular Templates
Patents related to climate change and rare diseases lead Molecular Templates's portfolio
Molecular Templates has the highest number of patents in climate change followed by, rare diseases. For climate change no patents were filed and 50% of patents were granted in Q2 2024.
Cosmetics & toiletries related patents lead Molecular Templates portfolio
Molecular Templates has highest number of patents in cosmetics & toiletries.
For comprehensive analysis of Molecular Templates's filings and grants, buy the databook here.
Data Insights
From
The gold standard of business intelligence.
Blending expert knowledge with cutting-edge technology, GlobalData’s unrivalled proprietary data will enable you to decode what’s happening in your market. You can make better informed decisions and gain a future-proof advantage over your competitors.